Chad Deal is a Rheumatology/Immunology physician affiliated with Cleveland Clinic. OpenAlex indexes 95 publications with 6,553 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
41 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
25.5%Opioid Agonist9%Tramadol Hcl86%Oxycodone-Acetaminophen14%Part D<11 patientsNonsteroidal Anti-inflammatory Drug8.1%Meloxicam68%Ibuprofen32%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
17.3%Folate Analog Metabolic Inhibitor6.6%Methotrexate91%Methotrexate Sodium9%Part D<11 patientsTNF inhibitor4.5%Humira Pen35%Humira(Cf) Pen24%Enbrel Sureclick15%Simponi14%Enbrel12%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
15.1%Corticosteroid7.5%Prednisone100%Part D≥57 patientsTissue-nonspecific Alkaline Phosphatase2.3%Strensiq100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Arthur McCullough, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”